News & Analysis as of

Medicare Advantage Organizations (MAOs) Medicare Inflation Reduction Act (IRA)

Latham & Watkins LLP

Healthcare & Life Sciences: Drug Pricing Digest - September 2025

Latham & Watkins LLP on

Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law....more

Wiley Rein LLP

Expanding Medicare Drug Pricing Implications in President Biden’s Proposed FY 2024 Budget

Wiley Rein LLP on

On March 9, 2023, the White House released President Biden’s proposed budget for fiscal year 2024 (FY 2024 Budget). The FY 2024 Budget, which the White House previewed in a March 7, 2023 fact sheet, contains numerous...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide